Recombinant CSF1R (Cabiralizumab Biosimilar) antibody

Catalog No. ABIN7581343

The Human Monoclonal anti-CSF1R (Cabiralizumab Biosimilar) antibody has been validated for ELISA, FACS, BLI, Func and SPR. It is suitable to detect CSF1R (Cabiralizumab Biosimilar) in samples from Human.

Quick Overview for Recombinant CSF1R (Cabiralizumab Biosimilar) antibody (ABIN7581343)

Target: CSF1R (Cabiralizumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This CSF1R (Cabiralizumab Biosimilar) antibody is un-conjugated

Application: ELISA, Flow Cytometry (FACS), Bio-Layer Interferometry (BLI), Functional Studies (Func), Surface Plasmon Resonance (SPR)

Product Details anti-CSF1R (Cabiralizumab Biosimilar) Antibody

Expression System: CHO Cells

Purpose: Anti-CSF1R / M-CSFR / CD115 Reference Antibody (cabiralizumab)

Characteristics: Anti-CSF1R / M-CSFR / CD115 Reference Antibody (cabiralizumab) is expressed from CHO. The heavy chain type is huIgG4SP, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.

Purity: >95 %

Isotype: IgG4 S228P

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Concentration: 1 mg/mL

Buffer: 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

Storage: 4 °C,-80 °C

Storage Comment: +4°C,-80°C

Target Details for CSF1R (Cabiralizumab Biosimilar)

Target: CSF1R (Cabiralizumab Biosimilar)

Target Type: Biosimilar

Molecular Weight: 145.5 kDa

UniProt: P07333